Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multicompartment Models: Overview01:14

Multicompartment Models: Overview

468
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
468
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.8K
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

246
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
246
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

491
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
491
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

9.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.9K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

293
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
293

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Wireless Photoplethysmography Chest Patch for Continuous Vital Sign Monitoring: A Clinical Validation Study in Intensive Care Patients.

Acta anaesthesiologica Scandinavica·2026
Same author

Wearable and wireless continuous monitoring for early detection of clinical deterioration in high-risk inpatients: a scoping review.

Intensive & critical care nursing·2026
Same author

Artificial intelligence for precision medicine.

Therapie·2025
Same author

Correction: Development and validation of a machine learning model for early prediction of intensive care unit acquired weakness.

Intensive care medicine experimental·2025
Same author

Development and validation of a machine learning model for early prediction of intensive care unit acquired weakness.

Intensive care medicine experimental·2025
Same author

Clinical profiles and temporal trends of 37,741 cardiovascular hospitalizations in Greece over 12 years: initial insights from the CardioMining database.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese·2025

Related Experiment Video

Updated: Jan 4, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K

Predicting Drug-Target Interactions With Multi-Label Classification and Label Partitioning.

Konstantinos Pliakos, Celine Vens, Grigorios Tsoumakas

    IEEE/ACM Transactions on Computational Biology and Bioinformatics
    |November 6, 2019
    PubMed
    Summary

    Predicting drug-target interactions aids drug discovery. This study improves multi-output learning by partitioning labels into groups, enhancing prediction accuracy for drug-target interactions.

    More Related Videos

    Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
    07:35

    Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

    Published on: October 11, 2018

    7.9K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.5K

    Related Experiment Videos

    Last Updated: Jan 4, 2026

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    12.5K
    Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
    07:35

    Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

    Published on: October 11, 2018

    7.9K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.5K

    Area of Science:

    • Computational Biology
    • Pharmacology
    • Machine Learning

    Background:

    • Identifying drug-target interactions is essential for drug discovery and repositioning.
    • Experimental methods for identifying drug-target interactions are time-consuming and resource-intensive.
    • In silico prediction methods, particularly multi-output learning, offer computational efficiency and high predictive performance.

    Purpose of the Study:

    • To improve the accuracy of in silico drug-target interaction prediction.
    • To address the limitations of the optimistic assumption in standard multi-output learning models.
    • To introduce a novel framework combining multi-label classification with label partitioning for enhanced prediction.

    Main Methods:

    • Framing drug-target interaction prediction as a multi-label classification problem.
    • Implementing label partitioning by grouping related drug-target interaction labels (clusters).
    • Developing and evaluating multi-output learning models on these partitioned label groups.

    Main Results:

    • Building multi-output learning models on clustered labels significantly improves prediction performance compared to standard approaches.
    • The proposed framework demonstrates superior results in predicting drug-target interactions.
    • Experimental validation confirms the efficiency and effectiveness of the label partitioning strategy.

    Conclusions:

    • Label partitioning is a more realistic and effective approach than assuming complete label correlation in multi-output learning for drug-target interaction prediction.
    • The developed framework offers a promising advancement for computational drug discovery.
    • This method can facilitate more efficient and accurate identification of potential drug candidates and repositioning opportunities.